The medical establishment is aggressively implementing biosignaling right now under different, heavily clinical names like Neuromodulation, Bioelectronic Medicine, and Electrophysiology (Garg et al., 2025; Lee et al., 2020).
Because these therapies are packaged as specialized medical hardware rather than consumer-facing "energy wellness," the broader public rarely realizes that the fundamental science governing them is the manipulation of the body's endogenous bioelectric fields and cellular voltage gates.
The $18+ billion bioelectric medicine market is functioning at the highest levels of healthcare through several major avenues (Lee et al., 2020):
Where Bioelectric Signaling is Active in Clinics Right Now
Vagus Nerve Stimulation (VNS): Implanted and non-invasive devices send electrical frequencies down the vagus nerve (Peeples, n.d.). This directly manipulates the cholinergic anti-inflammatory pathway, turning off systemic cytokine production (Lee et al., 2020). It is actively used to treat drug-resistant epilepsy, severe depression, and chronic inflammatory conditions like rheumatoid arthritis (Lee et al., 2020; Peeples, n.d.).
Deep Brain Stimulation (DBS): By introducing precise electrical currents into specific basal ganglia loops, clinicians physically override the aberrant bioelectric firing that causes Parkinson's disease tremors, dystonia, and severe obsessive-compulsive disorder (González-González et al., 2024).
Sacral & Spinal Cord Stimulation (SCS): Micro-current generators are surgically implanted to block chronic pain signals at the spinal dorsal column before they ever reach the brain (Garg, n.d.). This alters the neural circuit plasticity to treat treatment-resistant nerve pain (Garg, n.d.).
Tumor Treating Fields (TTFields): In oncology, FDA-approved wearable devices apply alternating electric fields to the scalp of glioblastoma (brain cancer) patients. These specific electric fields physically disrupt the bioelectric mechanics of cancer cell division (mitosis), slowing tumor progression without the systemic toxicity of standard chemotherapy.
Why Does It Feel Like It’s Being "Hidden"?
If this tech is so powerful and widely used, why isn't it front-page news? There are distinct institutional dynamics keeping it out of the public eye:
The Pharmaceutical Monopoly on Medical Education
For over a century, western medical schools have been built entirely around a chemical paradigm (molecular medicine). Doctors are trained to look at the body as a bag of chemical receptors to be bound by drugs. When a bioelectric device is introduced, it is categorized as a specialized "medical device" managed by neurosurgeons or urologists, rather than being taught as foundational bioelectric biology to general practitioners.
Extreme Regulatory Gating
Because the FDA and international regulatory bodies classify anything altering the body's electrical state as a high-risk medical device, getting these technologies to market requires hundreds of millions of dollars and strict clinical trials (Garg et al., 2025). The industry protects this data behind dense patent walls and rigorous academic jargon, making it inaccessible to the average person.
Fear of "Fringe" Stigmatization
Mainstream science goes to extreme lengths to distance itself from 20th-century "electro-therapy" scams or unvetted wellness claims. To maintain professional credibility, institutions deliberately scrub any "mystical" or overly broad sounding language. They will never say they are "adjusting your bioenergy field"; instead, they will report that they are "modulating the hyper-excitable neural circuitry via low-voltage charge-transfer conductive polymers" (Garg et al., 2025; Lee et al., 2020).
The Future: From Neural Circuits to Cellular Voltage
Right now, clinical implementation mostly targets the nervous system because nerves are the body's obvious "highways" for electrical signals (Lee et al., 2020).
The technology is real, it is approved, and it is actively altering human biology in hospitals worldwide. The challenge isn't discovering it—it's understanding the translations.
References
Chen, N. (2025). Bioelectric cues from piezoelectric materials in stem-cell adhesion and migration.
Frontiers in Cell and Developmental Biology, 13, Article 1707436. Garg, I., Verma, M., Kumar, H., Maurya, R., Negi, T., & Jain, P. (2025). Bioelectronic Therapeutics: A Revolutionary Medical Practice in Health Care. Bioelectricity, 7(1).
https://doi.org/10.1089/bioe.2024.0039 Cited by: 6
González-González, M. A., Conde, S. V., Latorre, R., Thébault, S. C., Pratelli, M., Spitzer, N. C., Verkhratsky, A., Tremblay, M.-È., Akcora, C. G., Hernández-Reynoso, A. G., Ecker, M., Coates, J., Vincent, K. L., & Ma, B. (2024). Bioelectronic Medicine: a multidisciplinary roadmap from biophysics to precision therapies.
Frontiers in Integrative Neuroscience, 18, Article 1321872. https://doi.org/10.3389/fnint.2024.1321872 Cited by: 47
Kerestély, M. (2025). Modulation of Network Plasticity Opens Novel Therapeutic Possibilities in Cancer, Diabetes, and Neurodegeneration.
EMBO Molecular Medicine, 17(2), Article 12948214. Cited by: 1
Lee, S. K., Jeakins, G. S., Tukiainen, A., Hewage, E., & Armitage, O. E. (2020). Next-Generation Bioelectric Medicine: Harnessing the Therapeutic Potential of Neural Implants. Bioelectricity, 2(4), 321-327.
https://doi.org/10.1089/bioe.2020.0044 Cited by: 15
Peeples, L. (n.d.). The rise of bioelectric medicine sparks interest among researchers, patients, and industry. Proceedings of the National Academy of Sciences.
Cited by: 37



